RhumbLine Advisers
BSX icon

RhumbLine Advisers’s Boston Scientific BSX Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$294M Sell
2,737,625
-58,819
-2% -$6.32M 0.25% 59
2025
Q1
$282M Buy
2,796,444
+55,006
+2% +$5.55M 0.26% 60
2024
Q4
$245M Sell
2,741,438
-113,403
-4% -$10.1M 0.22% 72
2024
Q3
$239M Sell
2,854,841
-104,581
-4% -$8.76M 0.22% 75
2024
Q2
$228M Sell
2,959,422
-11,466
-0.4% -$883K 0.21% 78
2024
Q1
$203M Buy
2,970,888
+14,602
+0.5% +$1M 0.2% 93
2023
Q4
$171M Buy
2,956,286
+8,634
+0.3% +$499K 0.18% 100
2023
Q3
$156M Buy
2,947,652
+24,133
+0.8% +$1.27M 0.18% 97
2023
Q2
$158M Buy
2,923,519
+15,558
+0.5% +$842K 0.18% 95
2023
Q1
$145M Sell
2,907,961
-17,212
-0.6% -$861K 0.18% 100
2022
Q4
$135M Buy
2,925,173
+194,639
+7% +$9.01M 0.18% 108
2022
Q3
$106M Buy
2,730,534
+66,703
+3% +$2.58M 0.16% 114
2022
Q2
$99.3M Buy
2,663,831
+98,798
+4% +$3.68M 0.14% 129
2022
Q1
$114M Buy
2,565,033
+76,742
+3% +$3.4M 0.15% 122
2021
Q4
$106M Buy
2,488,291
+17,546
+0.7% +$745K 0.13% 132
2021
Q3
$107M Sell
2,470,745
-79,749
-3% -$3.46M 0.15% 122
2021
Q2
$109M Sell
2,550,494
-124,331
-5% -$5.32M 0.14% 125
2021
Q1
$103M Sell
2,674,825
-183,581
-6% -$7.1M 0.14% 129
2020
Q4
$103M Buy
2,858,406
+57,397
+2% +$2.06M 0.14% 131
2020
Q3
$107M Sell
2,801,009
-9,130
-0.3% -$349K 0.17% 114
2020
Q2
$98.7M Buy
2,810,139
+65,962
+2% +$2.32M 0.16% 119
2020
Q1
$89.5M Buy
2,744,177
+85,952
+3% +$2.8M 0.19% 104
2019
Q4
$120M Buy
2,658,225
+23,480
+0.9% +$1.06M 0.2% 96
2019
Q3
$107M Buy
2,634,745
+60,662
+2% +$2.47M 0.2% 97
2019
Q2
$111M Sell
2,574,083
-25,013
-1% -$1.08M 0.21% 88
2019
Q1
$99.8M Buy
2,599,096
+100,341
+4% +$3.85M 0.19% 97
2018
Q4
$88.3M Buy
2,498,755
+48,890
+2% +$1.73M 0.19% 99
2018
Q3
$94.3M Sell
2,449,865
-35,756
-1% -$1.38M 0.18% 110
2018
Q2
$81.3M Buy
2,485,621
+87,665
+4% +$2.87M 0.16% 123
2018
Q1
$65.5M Sell
2,397,956
-26,344
-1% -$720K 0.14% 154
2017
Q4
$60.1M Buy
2,424,300
+54,174
+2% +$1.34M 0.12% 172
2017
Q3
$69.1M Buy
2,370,126
+56,189
+2% +$1.64M 0.15% 137
2017
Q2
$64.1M Buy
2,313,937
+42,418
+2% +$1.18M 0.15% 143
2017
Q1
$56.5M Buy
2,271,519
+47,510
+2% +$1.18M 0.13% 159
2016
Q4
$48.1M Buy
2,224,009
+71,233
+3% +$1.54M 0.12% 176
2016
Q3
$51.2M Buy
2,152,776
+98,764
+5% +$2.35M 0.14% 144
2016
Q2
$48M Buy
2,054,012
+148,065
+8% +$3.46M 0.14% 140
2016
Q1
$35.9M Buy
1,905,947
+70,513
+4% +$1.33M 0.11% 185
2015
Q4
$33.8M Sell
1,835,434
-1,549
-0.1% -$28.6K 0.11% 186
2015
Q3
$30.1M Buy
1,836,983
+45,882
+3% +$753K 0.1% 202
2015
Q2
$31.7M Buy
1,791,101
+50,996
+3% +$903K 0.1% 207
2015
Q1
$30.9M Sell
1,740,105
-24,639
-1% -$437K 0.09% 212
2014
Q4
$23.4M Sell
1,764,744
-18,024
-1% -$239K 0.07% 265
2014
Q3
$21.1M Sell
1,782,768
-64,228
-3% -$759K 0.06% 272
2014
Q2
$23.6M Sell
1,846,996
-44,436
-2% -$567K 0.07% 263
2014
Q1
$25.6M Sell
1,891,432
-63,660
-3% -$861K 0.08% 244
2013
Q4
$23.5M Sell
1,955,092
-92,663
-5% -$1.11M 0.07% 266
2013
Q3
$24M Buy
2,047,755
+67,017
+3% +$787K 0.07% 259
2013
Q2
$18.4M Buy
+1,980,738
New +$18.4M 0.06% 306